Description of the Sphingolipid Content and Subspecies in the Diabetic Cornea

References

• Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335–1343
   PubMed Web of Science ®Google Scholar
• Gardner DG, Shoback D. Greenspan’s basic & clinical endocrinology. 9th ed. New York: McGraw-Hill Medical; 2011
   Google Scholar
• Skarbez K, Priestley Y, Hoepf M, Koevary SB. Comprehensive review of the effects of diabetes on ocular health. Expert Rev Ophthalmol 2010;5:557–577
   PubMedGoogle Scholar
• Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt 1988;65:224–230
   PubMedGoogle Scholar
• Owen CG, Newsom RS, Rudnicka AR, Ellis TJ, Woodward EG. Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology 2005;112:1801–1808
   PubMed Web of Science ®Google Scholar
• Schultz RO, Matsuda M, Yee RW, Edelhauser HF, Schultz KJ. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol 1984;98:401–410
   PubMed Web of Science ®Google Scholar
• Mishima S. The effects of the denervation and the stimulation of the sympathetic and the trigeminal nerve on the mitotic rate of the corneal epithelium in the rabbit. Jpn J Ophthalmol 1957;1:65–73
   Google Scholar
• Alper MG. The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course. Trans Am Ophthalmol Soc 1975;73:323–365
   PubMedGoogle Scholar
• Araki K, Ohashi Y, Kinoshita S, Hayashi K, Kuwayama Y, Tano Y. Epithelial wound healing in the denervated cornea. Curr Eye Res 1994;13:203–211
   PubMed Web of Science ®Google Scholar
• Baker KS, Anderson SC, Romanowski EG, Thoft RA, SundarRaj N. Trigeminal ganglion neurons affect corneal epithelial phenotype. Influence on type VII collagen expression in vitro. IOVS 1993;34:137–144
   PubMed Web of Science ®Google Scholar
• Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298:2654–2664
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653
   PubMed Web of Science ®Google Scholar
• The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122:561–568
   Google Scholar
• Cavanagh PR. Therapeutic footwear for people with diabetes. Diabetes MetabResearch Rev 2004;20 Suppl 1:S51–S55
   Web of Science ®Google Scholar
• Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 1979;97:1076–1078
   PubMed Web of Science ®Google Scholar
• Chung H, Tolentino FI, Cajita VN, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol 1988;106:916–919
   PubMed Web of Science ®Google Scholar
• Saini JS, Khandalavla B. Corneal epithelial fragility in diabetes mellitus. CanJ Ophthalmol 1995;30:142–146
   PubMed Web of Science ®Google Scholar
• Hatchell DL, Magolan JJ, Jr Besson MJ, Goldman AI, Pederson HJ, Schultz KJ. Damage to the epithelial basement membrane in the corneas of diabetic rabbits. Arch Ophthalmol 1983;101:469–471
   PubMed Web of Science ®Google Scholar
• Dahlquist G. The aetiology of type 1 diabetes: an epidemiological perspective. Acta paediatr 1998;87:5–10
   Web of Science ®Google Scholar
• Bono VH. Review of mechanism of action studies of nitrosoureas. Cancer Treat Rep 1976;60:699–702
   PubMedGoogle Scholar
• Wang ZY, Gleichmann H. GLUT2 in pancreatic islets – crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 1998;47:50–56
   PubMed Web of Science ®Google Scholar
• Zahner D, Malaisse WJ. Kinetic behaviour of liver glucokinase in diabetes. I. Alteration in streptozotocin-diabetic rats. J Diabetes Res 1990;14:101–108
   Google Scholar
• Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002;512:121–134
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. Pancreas 2003;26:e99–e104
   PubMedGoogle Scholar
• Mensah-Brown EP, Stosic Grujicic S, Maksimovic D, Jasima A, Shahin A, Lukic ML. Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol Immunol 2002;38:941–946
   PubMed Web of Science ®Google Scholar
• Muller A, Schott-Ohly P, Dohle C, Gleichmann H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 2002;205:35–50
   PubMed Web of Science ®Google Scholar
• Holstad M, Sandler S. A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice. J Autoimmun 2001;16:441–447
   PubMed Web of Science ®Google Scholar
• Zuccollo A, Navarro M, Frontera M, Cueva F, Carattino M, Catanzaro OL. The involvement of kallikrein-kinin system in diabetes type I (insulitis). Immunopharmacology 1999;45:69–74
   PubMed Web of Science ®Google Scholar
• Herold KG, Lenschow DJ, Bluestone JA. CD28/B7 regulation of autoimmune diabetes. Immunol Res 1997;16:71–84
   PubMed Web of Science ®Google Scholar
• Reddy S, Wu D, Elliott RB. Low-dose streptozotocin causes diabetes in severe combined immunodeficient (Scid) mice without immune cell infiltration of the pancreatic-islets. Autoimmunity 1995;20:83–92
   PubMed Web of Science ®Google Scholar
• Arata M, Fabiano de Bruno L, Goncalvez Volpini WM, Quintans JC, D’Alessandro VG, Braun M, et al. Beta-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice. Proc Soc Exp Biol Med 1994;206:76–82
   PubMed Web of Science ®Google Scholar
• Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002;34:207–216
   PubMed Web of Science ®Google Scholar
• Krook A, O’Rahilly S. Mutant insulin receptors in syndromes of insulin resistance. Baillieres Best Pract ResClin Endocrinol Metab 1996;10:97–122
   PubMed Web of Science ®Google Scholar
• Maassen JA, T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 2004;53:S103–S109
   PubMed Web of Science ®Google Scholar
• Leibel RL, Chung WK, Chua SC. Jr The molecular genetics of rodent single gene obesities. The JBC 1997;272:31937–31940
   PubMed Web of Science ®Google Scholar
• Chagnon YC, Bouchard C. Genetics of obesity: advances from rodent studies. TIG 1996;12:441–444
   PubMed Web of Science ®Google Scholar
• Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homolog. Nature 1994;372:425–432
   PubMed Web of Science ®Google Scholar
• Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–635
   PubMed Web of Science ®Google Scholar
• Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996;13:18–19
   PubMed Web of Science ®Google Scholar
• Bu S, Asano Y, Bujor A, Highland K, Hant F, Trojanowska M. Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis Rheum 2010;62:2117–2126
   PubMed Web of Science ®Google Scholar
• Li C, Jiang X, Yang L, Liu X, Yue S, Li L. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol 2009;175:1464–1472
   PubMed Web of Science ®Google Scholar
• Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol 2010;43:662–673
   PubMed Web of Science ®Google Scholar
• Swaney JS, Moreno KM, Gentile AM, Sabbadini RA, Stoller GL. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Exp Eye Res 2008;87:367–375
   PubMed Web of Science ®Google Scholar
• Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, et al. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res 2010;85:484–493
   PubMed Web of Science ®Google Scholar
• Wijesinghe DS, Allegood JC, Gentile LB, Fox TE, Kester M, Chalfant CE. Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels. J Lipid Res 2010;51:641–651
   PubMed Web of Science ®Google Scholar
• Wijesinghe DS, Brentnall M, Mietla JA, Hoeferlin LA, Diegelmann RF, Boise LH, et al. Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fibroblasts. J Lipid Res 2014;55:1298–1309
   PubMed Web of Science ®Google Scholar
• Mietla JA, Wijesinghe DS, Hoeferlin LA, Shultz MD, Natarajan R, Fowler AA, et al. Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase. J Lipid Res 2013;54:1834–1847
   PubMed Web of Science ®Google Scholar
• Poretsky L. Principles of diabetes mellitus. 2nd ed. New York: Springer; 2009
   Google Scholar
• Lambert P, Bingley PJ. What is type 1 diabetes? Medicine 2002;30:1–5
   Google Scholar
• Rother KI. Focus on research: diabetes treatment – bridging the divide. New Engl J Med 2007;356:1499–1501
   PubMed Web of Science ®Google Scholar
• David GG, Dolores S. Greenspan's basic & clinical endocrinology, 9th ed, Chapter 17. New York: McGraw-Hill Medical; 2011
   Google Scholar
• Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009;48:44–51
   PubMed Web of Science ®Google Scholar
• Lutty GA. Effects of diabetes on the eye. IOVS 2013;54:ORSF81–7
   PubMed Web of Science ®Google Scholar
• Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981;79:180–199
   PubMedGoogle Scholar
• Schultz RO, Peters MA, Sobocinski K, Nassif K, Schultz KJ. Diabetic keratopathy as a manifestation of peripheral neuropathy. Am J Ophthalmol 1983;96:368–371
   PubMed Web of Science ®Google Scholar
• Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001;108:586–592
   PubMed Web of Science ®Google Scholar
• Yoon KC, Im SK, Seo MS. Changes of tear film and ocular surface in diabetes mellitus. Korean J Ophthalmol: KJO 2004;18:168–174
   PubMedGoogle Scholar
• Goebbels M. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol 2000;84:19–21
   PubMed Web of Science ®Google Scholar
• Saito J, Enoki M, Hara M, Morishige N, Chikama T, Nishida T. Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003;22:15–18
   PubMed Web of Science ®Google Scholar
• Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea 2001;20:798–801
   PubMed Web of Science ®Google Scholar
• Schwartz DE. Corneal sensitivity in diabetics. Arch Ophthalmol 1974;91:174–178
   PubMed Web of Science ®Google Scholar
• Rosenberg ME, Tervo TM, Immonen IJ, Muller LJ, Gronhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. IOVS 2000;41:2915–2921
   PubMed Web of Science ®Google Scholar
• Gekka M, Miyata K, Nagai Y, Nemoto S, Sameshima T, Tanabe T, et al. Corneal epithelial barrier function in diabetic patients. Cornea 2004;23:35–37
   PubMed Web of Science ®Google Scholar
• Gobbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefe’s Arch Clin Exp Ophthalmol 1989;227:142–144
   PubMed Web of Science ®Google Scholar
• Busted N, Olsen T, Schmitz O. Clinical Observations on the corneal thickness and the corneal endothelium in diabetes-mellitus. Brit J Ophthalmol 1981;65:687–690
   PubMed Web of Science ®Google Scholar
• Su DH, Wong TY, Wong WL, Saw SM, Tan DT, Shen SY, et al. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology 2008;115:964–968 e1
   PubMed Web of Science ®Google Scholar
• Saini JS, Mittal S. In vivo assessment of corneal endothelial function in diabetes mellitus. Arch Ophthalmol 1996;114:649–653
   PubMed Web of Science ®Google Scholar
• Lee JS, Oum BS, Choi HY, Lee JE, Cho BM. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye 2006;20:315–318
   PubMed Web of Science ®Google Scholar
• Kolesnick R. Signal-Transduction through the sphingomyelin pathway. Mol Chem Neuropathol 1994;21:287–297
   PubMedGoogle Scholar
• Green DR. Apoptosis and sphingomyelin hydrolysis: the flip side. J Cell Biol 2000;150:F5–F7
   PubMed Web of Science ®Google Scholar
• Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994;180:525–535
   PubMed Web of Science ®Google Scholar
• Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, et al. p53-Dependent ceramide response to genotoxic stress. J Clin Invest 1998;102:329–339
   PubMed Web of Science ®Google Scholar
• Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R. Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem 2005;280:26425–26434
   PubMed Web of Science ®Google Scholar
• Dbaibo GS, El-Assaad W, Krikorian A, Liu B, Diab K, Idriss NZ, et al. Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett 2001;503:7–12
   PubMed Web of Science ®Google Scholar
• Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006;1758:2027–2036
   PubMed Web of Science ®Google Scholar
• Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 2003;1632:16–30
   PubMed Web of Science ®Google Scholar
• Kihara A, Igarashi Y. FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. J Biol Chem 2004;279:49243–49250
   PubMed Web of Science ®Google Scholar
• Michel C, vanEchtenDeckert G. Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum. FEBS Lett 1997;416:153–155
   PubMed Web of Science ®Google Scholar
• van Helvoort A, van’t Hof W, Ritsema T, Sandra A, van Meer G. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase. J Biol Chem 1994;269:1763–1769
   PubMed Web of Science ®Google Scholar
• Futerman AH, Stieger B, Hubbard AL, Pagano RE. Sphingomyelin synthesis in rat-liver occurs predominantly at the Cis and medial cisternae of the golgi-apparatus. J Biol Chem 1990;265:8650–8657
   PubMed Web of Science ®Google Scholar
• Perry RJ, Ridgway ND. Molecular mechanisms and regulation of ceramide transport. Biochim Biophys Acta 2005;1734:220–234
   PubMed Web of Science ®Google Scholar
• Sprong H, Kruithof B, Leijendekker R, Slot JW, van Meer G, van der Sluijs P. UDP-galactose:ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum. J Biol Chem 1998;273:25880–25888
   PubMed Web of Science ®Google Scholar
• van Meer G, Holthuis JC. Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta 2000;1486:145–170
   PubMed Web of Science ®Google Scholar
• Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004;82:27–44
   PubMed Web of Science ®Google Scholar